Small heterodimer partner attenuates profibrogenic features of hepatitis C virus‐infected cells
暂无分享,去创建一个
W. Jeong | In-kyu Lee | Mi-kyung Kim | G. Jung | K. Park | E. Shin | S. Park | S. Jang | J. Jeon | Yeon-Kyung Choi | Y. Kang
[1] T. Therneau,et al. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes , 2014, Hepatology.
[2] D. Samuel,et al. HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment. , 2013, Journal of hepatology.
[3] Leiliang Zhang,et al. The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling. , 2013, Journal of hepatology.
[4] P. André,et al. Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF‐β signaling , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] G. Waris,et al. Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion , 2013, PloS one.
[6] K. Ghoshal,et al. Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes , 2012, PloS one.
[7] In-kyu Lee,et al. Orphan Nuclear Receptor Small Heterodimer Partner Negatively Regulates Growth Hormone-mediated Induction of Hepatic Gluconeogenesis through Inhibition of Signal Transducer and Activator of Transcription 5 (STAT5) Transactivation* , 2012, The Journal of Biological Chemistry.
[8] D. Brigstock,et al. Regulation of hepatic stellate cells by connective tissue growth factor. , 2012, Frontiers in bioscience.
[9] Y. H. Kim,et al. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models , 2012, Diabetologia.
[10] D. Moore,et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors , 2011, Nature Immunology.
[11] E. Vicaut,et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. , 2011, The Journal of clinical endocrinology and metabolism.
[12] Leiliang Zhang,et al. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. , 2010, Gastroenterology.
[13] B. Viollet,et al. Development of hepatic fibrosis occurs normally in AMPK-deficient mice. , 2010, Clinical science.
[14] In-kyu Lee,et al. The orphan nuclear receptor SHP attenuates renal fibrosis. , 2009, Journal of the American Society of Nephrology : JASN.
[15] In-kyu Lee,et al. Fenofibrate differentially regulates plasminogen activator inhibitor‐1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner , 2009, Hepatology.
[16] A. Gressner,et al. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[17] Hueng-Sik Choi,et al. Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. , 2008, Endocrine journal.
[18] In-kyu Lee,et al. Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP , 2008, Diabetes.
[19] S. Gelmini,et al. Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells , 2007, Hepatology.
[20] Keesook Lee,et al. Orphan Nuclear Receptor Small Heterodimer Partner Inhibits Transforming Growth Factor-β Signaling by Repressing SMAD3 Transactivation* , 2006, Journal of Biological Chemistry.
[21] D. Schuppan,et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. , 2005, Gastroenterology.
[22] C. W. Kim,et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1 , 2005, Experimental & Molecular Medicine.
[23] A. Morelli,et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.
[24] G. Davis,et al. Projecting future complications of chronic hepatitis C in the United States , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] D. Roulot,et al. Transforming growth factor β and the liver , 2001 .
[26] R. Schulte‐Hermann,et al. Biology of transforming growth factor β in hepatocarcinogenesis , 2001, Microscopy research and technique.
[27] L. Seeff,et al. Natural history of hepatitis C , 1997, Hepatology.
[28] P. Bedossa,et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.
[29] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[30] K. Batts,et al. Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.
[31] D M Bissell,et al. Transforming growth factor beta and the liver. , 2001, Hepatology.
[32] R. W. Mccollum. The natural history of hepatitis. , 1969, Bulletin of the New York Academy of Medicine.